SCHEMBL2370055

SCHEMBL2370055

CCCCCCCCCCCCCCCC(O)OP(=O)(O)O

nearest known ligand 0.69

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 3/20 0.69
PTPN1 P18031 1/20 0.58
FDPS P14324 5/20 0.53
S1PR2 O95136 5/20 0.50
S1PR1 P21453 5/20 0.50
S1PR3 Q99500 5/20 0.50
S1PR4 O95977 4/20 0.50
LAP3 P28838 2/20 0.50
LPAR3 Q9UBY5 3/20 0.48
LPAR1 Q92633 2/20 0.48
LPAR2 Q9HBW0 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2514364 1.00 SMPD1 (0.69) SMPD1PTPN1FDPSS1PR2S1PR1
SCHEMBL11619477 1.00 SMPD1 (0.69) SMPD1PTPN1FDPSS1PR2S1PR1
SCHEMBL28470942 1.00 SMPD1 (0.69) SMPD1PTPN1FDPSS1PR2S1PR1
Ammonia Solution, Strong SCHEMBL28408668 0.98 SMPD1 (0.67) SMPD1PTPN1FDPSS1PR2S1PR1
SCHEMBL28701575 0.98 SMPD1 (0.67) SMPD1PTPN1FDPSS1PR2S1PR1
SCHEMBL8682289 0.98 SMPD1 (0.66) SMPD1PTPN1FDPSS1PR2S1PR1
SCHEMBL210519 0.92 SMPD1 (0.57) SMPD1PTPN1FDPSS1PR2S1PR1
SCHEMBL28114269 0.90 SMPD1 (0.57) SMPD1PTPN1S1PR2S1PR1S1PR3
SCHEMBL2370049 0.86 SMPD1 (0.55) SMPD1PTPN1FDPSS1PR2S1PR1
SCHEMBL8408110 0.86 SMPD1 (0.55) SMPD1PTPN1FDPSS1PR2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122055131-A Composition for sebum control 戴森运营私人有限公司 2026-05-15 CN disclosed
US-12257335-B2 Personal care compositions COLGATE-PALMOLIVE COMPANY (US) 2025-03-25 US disclosed
CN-119255786-A Oleanolic acid composition for sebum control 戴森运营私人有限公司 2025-01-03 CN disclosed
US-12083212-B2 Personal care compositions COLGATE-PALMOLIVE COMPANY (US) 2024-09-10 US disclosed
CN-113164361-B Personal care compositions 高露洁-棕榄公司 2024-04-02 CN disclosed
US-20230210747-A1 Anti-Ageing Cosmetic Compositions for Men and Women, Containing Bioactive Protein, and the Method of its Production REELABS, INC. 2023-07-06 US disclosed
CN-114599334-A Stable low pH personal care compositions and methods therefor 高露洁-棕榄公司 2022-06-07 CN disclosed
US-20220023189-A1 Personal Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2022-01-27 US disclosed
US-20220000755-A1 Personal Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2022-01-06 US disclosed
CN-113710329-A Personal care compositions 高露洁-棕榄公司 2021-11-26 CN disclosed
EP-2040555-A2 FORMULATED TICK AND INSECT REPELLENT COMPOSITIONS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-04-01 EP disclosed
CN-101132756-A Personal care composition containing hydrophobically modified polymers NALCO CO (US) 2008-02-27 CN disclosed
WO-2007133683-A2 FORMULATED TICK AND INSECT REPELLENT COMPOSITIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-11-22 WO disclosed
US-20070264297-A1 Formulated tick and insect repellent compositions 1,4Group, Inc. 2007-11-15 US disclosed
US-20060223878-A1 Formulations containing insect repellent compounds 1,4Group, Inc. 2006-10-05 US disclosed
EP-1171094-B1 WET WIPES HAVING SKIN HEALTH BENEFITS KIMBERLY CLARK CO (US) 2006-06-28 EP disclosed
US-6440437-B1 OIL IN WATER EMULSION COMPRISING NATURAL FAT OR OIL, STEROL, HUMECTANT, SURFACTANT, AND WATER; ENHANCES SKIN BARRIER; BABY OR HAND WIPES KIMBERLY-CLARK WORLDWIDE, INC. 2002-08-27 US disclosed
EP-1171094-A1 WET WIPES HAVING SKIN HEALTH BENEFITS Kimberly-Clark Worldwide, Inc. (US) 2002-01-16 EP disclosed
WO-2000064408-A1 WET WIPES HAVING SKIN HEALTH BENEFITS KIMBERLY-CLARK WORLDWIDE, INC. (US) 2000-11-02 WO disclosed
WO-1998048768-A9 COMPOSITIONS FOR COSMETIC APPLICATIONS MEDLOGIC GLOBAL CORP (US) 1999-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223878-A1 Formulations containing insect repellent compounds CAT, HNMT, MME SMPD1 445/4885PTPN1 4430/4885FDPS 1901/4885
US-20070264297-A1 Formulated tick and insect repellent compositions MME, FNTA, ACHE SMPD1 146/4885PTPN1 2838/4885FDPS 289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.